Abeona Therapeutics ($ABEO) Insider Trading & Smart Money Activity
Abeona Therapeutics Inc. ($ABEO) has 6 insider trades and 2 13F position changes on file. In the last 12 months on the open market, no insider bought and 5 insiders sold ($312.12K), net -$312.12K.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 5
- Net insider $ (12 mo)
- -$312.12K
- Congress trades (12 mo)
- 0
- 13F moves on file
- 2
- Analyst ratings on file
- 0
ABEO insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 1 · $103.69K | 0 / 0 | 0 / 2 |
| Q3 2026 | 0 | 4 · $208.43K | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All ABEO insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insider | Vazzano Joseph WalterChief Financial Officer | Sell (Open-market sale) | 9.19K sh | $47.39K | -2.9% | — | |||||
| Insider | Vasanthavada MadhavChief Commercial Officer | Sell (Open-market sale) | 4.90K sh | $25.27K | -2.9% | — | |||||
| Insider | Seshadri VishwasChief Executive Officer | Sell (Open-market sale) | 19.61K sh | $101.09K | -2.9% | — | |||||
| Insider | O'Malley Brendan M.SVP, Chief Legal Officer | Sell (Open-market sale) | 6.73K sh | $34.68K | -2.9% | — | |||||
| Insider | Madhav VasanthavadaChief Commercial Officer | Sell (Other) | 222 sh | $1.26K | +1.2% | +24.2% | — | ||||
| Insider | Silverstein Christine Berni | Sell (Open-market sale) | 18.16K sh | $103.69K | +1.4% | +28.6% | Read | ||||
| 13F | Group One Trading | Reduced | -114.38K sh | $1.24M | -6.8% | -3.2% | — | ||||
| 13F | Group One Trading | Reduced | -114.38K sh | $1.16M | -6.8% | -3.2% | — |
1W / 1M / 6M = how ABEO moved from the trade or filing date.
Insider trading in ABEO: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Vazzano Joseph Walter | Chief Financial Officer | 1 | -$47.39K | Sep 29, 2026 | |
| Vasanthavada Madhav | Chief Commercial Officer | 1 | -$25.27K | Sep 29, 2026 | |
| Seshadri Vishwas | Chief Executive Officer | 1 | -$101.09K | Sep 29, 2026 | |
| O'Malley Brendan M. | SVP, Chief Legal Officer | 1 | -$34.68K | Sep 29, 2026 | |
| Madhav Vasanthavada | Chief Commercial Officer | 1 | — | Jun 16, 2026 | |
| Silverstein Christine Berni | 1 | -$103.69K | Jun 15, 2026 |
Institutions moving ABEO (13F)
Frequently asked questions
Are ABEO insiders buying or selling?
Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 5 insiders made 5 open-market sales worth $312.12K, a net -$312.12K.
What is the latest insider trade in ABEO?
Vazzano Joseph Walter, Chief Financial Officer filed a sell (open-market sale) of 9.19K sh worth $47.39K on Sep 29, 2026.
Which institutions changed their ABEO positions?
Recent 13F filers moving the stock include Group One Trading.
Other biotechnology stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.